Abstract
This chapter deals with the marine biopharmaceuticals in the pipeline i.e.
year-wise number of approved marine drugs during the period 1969-2021 and their
clinical uses; approved and marketed drugs up to 2021; marine biota-derived drug
candidates under the different phases of clinical trials up to 2021; and marine
biotaderived clinical level compounds against SARS-CoV-2.
Keywords: Marine biopharmaceuticals in the pipeline, Year-wise approved marine drugs, Clinical uses of approved marine drugs, Marketed marine drugs up to 2021, and clinically tested marine compounds against SARS-CoV-2.